Metabolic & Endocrine
Thyroid Disease
8
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Thyroid Disease is an early-stage landscape with 8 programs across 1 company. The most active players are Bayer. 1 therapy is approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
7
clinical trials
Completed3 · 43%
Unknown status3 · 43%
Recruiting1 · 14%
Clinical Trials
Trial Activity
7 trials
Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening
Completed·—·N/A·NCT00846755·4,657 enrolled
the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake
Unknown status·TTianjin Medical University Cancer Institute and Hospital·Phase 1/2·NCT01873014·400 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)